Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2(V617F) allelic burden

BACKGROUND: Pegylated-interferon alpha (PegINFα) treatment of patients with polycythemia vera (PV) and essential thrombocythemia (ET) has resulted in long-term clinical response, decreased JAK2 (V617F) allelic burden and restoration of polyclonal hematopoiesis. The mechanisms of the beneficial effec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Exp Hematol Oncol
Glavni autori: Kovacsovics-Bankowski, Magdalena, Kelley, Todd W., Efimova, Olga, Kim, Soo Jin, Wilson, Andrew, Swierczek, Sabina, Prchal, Josef
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5037882/
https://ncbi.nlm.nih.gov/pubmed/27708986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0057-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items